Nabi Tauseef, Rafiq Nadeema, Rahman Mohammad Hifz Ur, Rasool Shahnawaz, Wani Nayeem U Din
Department of Endocrinology, MMIMSR, Ambala, Haryana India.
Department of Physiology, Govt. Medical College, Baramulla, J&K India.
J Diabetes Metab Disord. 2020 Sep 28;19(2):1273-1282. doi: 10.1007/s40200-020-00640-y. eCollection 2020 Dec.
Emphysematous pyelonephritis (EPN) patients with type 2 diabetes (T2D) have severe complications and high morbidity with poor prognosis as compared to Pyelonephritis. The aim was to study clinical features, microbiological profile, complications of EPN and pyelonephritis in T2D patients.
This was a hospital-based prospective study done on 200 T2D patients with upper UTI. Various clinical, biochemical parameters and urine examination and culture were monitored. Patients were followed up for 6 months with respect to number of UTIs, glycemic control and renal parameters.
Pyelonephritis was present in 180(90%) and EPN in 20(10%) of upper UTI patients. Longer duration of diabetes, presence of nephropathy, chronic kidney disease (CKD), hypertension (HTN), history of symptomatic UTI in a prior year, renal calculi and obstruction increase the risk of EPN. Patients with EPN commonly present with vomiting, flank pain altered sensorium and renal tenderness. Complications like diabetic ketoacidosis (DKA), hyperglycemic hyperosmolar state (HHS), multiorgan dysfunction syndrome (MODS), acute kidney injury (AKI) and hypotension occur frequently in EPN as compared to pyelonephritis in T2D patients. Patients with EPN had poor glycemia and lower estimated glomerular filtration rate (eGFR) as compared to pyelonephritis. Bacteriuria was present in 90% and 66.7% of EPN and pyelonephritis patients respectively. was the most common isolate in both UTI groups. A significant number of EPN patients develop recurrent UTI. Patients with EPN have an improvement in glycemia on follow up, but renal parameters do not improve on follow up, while as pyelonephritis patients have an improvement in glycemia and renal parameters with intensive treatment. Recurrent UTI in upper UTI patients leads to worsening of glycemia and renal parameters.
Complications frequently occur in EPN patients as compared to pyelonephritis.
与肾盂肾炎相比,2型糖尿病(T2D)合并气肿性肾盂肾炎(EPN)患者并发症严重、发病率高且预后较差。本研究旨在探讨T2D患者EPN和肾盂肾炎的临床特征、微生物学特征及并发症。
这是一项基于医院的前瞻性研究,对200例患有上尿路感染的T2D患者进行了研究。监测了各种临床、生化参数以及尿液检查和培养结果。对患者进行了6个月的随访,观察尿路感染次数、血糖控制情况和肾脏参数。
上尿路感染患者中,180例(90%)患有肾盂肾炎,20例(10%)患有EPN。糖尿病病程较长、存在肾病、慢性肾脏病(CKD)、高血压(HTN)、前一年有症状性尿路感染病史、肾结石和尿路梗阻会增加EPN的发病风险。EPN患者通常表现为呕吐、胁腹痛、意识改变和肾区压痛。与T2D患者的肾盂肾炎相比,EPN患者更常出现糖尿病酮症酸中毒(DKA)、高血糖高渗状态(HHS)、多器官功能障碍综合征(MODS)、急性肾损伤(AKI)和低血压等并发症。与肾盂肾炎患者相比,EPN患者血糖控制较差,估计肾小球滤过率(eGFR)较低。EPN和肾盂肾炎患者的菌尿症发生率分别为90%和66.7%。 是两个尿路感染组中最常见的分离菌。相当数量的EPN患者会发生复发性尿路感染。EPN患者随访时血糖有所改善,但肾脏参数无改善,而肾盂肾炎患者强化治疗后血糖和肾脏参数均有改善。上尿路感染患者复发性尿路感染会导致血糖和肾脏参数恶化。
与肾盂肾炎相比,EPN患者并发症频发。